Vera Therapeutics (VERA) Interest & Investment Income (2020 - 2026)
Vera Therapeutics (VERA) posted Interest & Investment Income of $6.4 million for Q1 2026, up 15.19% on a QoQ basis from $5.5 million in Q4 2025, and down 7.98% year-over-year from $6.9 million in Q1 2025.
Vera Therapeutics (VERA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Vera Therapeutics' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- Quarterly Interest & Investment Income fell 7.98% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (up 2.11% YoY) and the FY2025 annual result came in at $24.5 million, up 18.18% from the prior year.
- Interest & Investment Income was $6.4 million for Q1 2026 at Vera Therapeutics, up from $5.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $6.9 million in Q1 2025 and bottomed at $26000.0 in Q1 2022.
- A 5-year average of $3.6 million and a median of $4.2 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 14800.0% — and 2025, when it dropped 17.2%.
- Vera Therapeutics' Interest & Investment Income stood at $894000.0 in 2022, then jumped by 119.24% to $2.0 million in 2023, then surged by 239.95% to $6.7 million in 2024, then fell by 17.2% to $5.5 million in 2025, then increased by 15.19% to $6.4 million in 2026.
- Business Quant data shows VERA's Interest & Investment Income at $6.4 million in Q1 2026, $5.5 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Vera Therapeutics | 2.55 Bn | 2.55 Bn | - | 6.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.91 Mn |
| Dec 31, 2024 | 6.66 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 894,000.00 |
| Sep 30, 2022 | 567,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 2,000.00 |